Expanded Magstim TMS Coverage Opens New Access for U.S. Adolescent Patients*
By Amy Banks
More U.S. insurance providers are now expanding coverage to include TMS treatment for adolescents (ages 15+) with Major Depressive Disorder—creating a new path to care for younger patients who need additional options. This means practices using FDA-cleared Magstim Horizon and Inspire TMS systems may be able to treat adolescent patients, pending prior authorization, under updated policies from major insurers including Optum, Aetna, … Continued